Nuveen Asset Management, LLC Allakos Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.02 - $3.23 $44,000 - $139,335	43,138 Added 20.52%	253,367 $319,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $76,166 - $140,819	-44,283 Reduced 17.4%	210,229 $573,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $30,218 - $78,737	14,187 Added 5.9%	254,512 $577,000
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $771,397 - $1.12 Million	214,277 Added 822.62%	240,325 $1.05 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $112,006 - $215,416	26,048 New	26,048 $115,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $272,222 - $642,864	-104,701 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $3,942 - $7,612	776 Added 0.75%	104,701 $8.52 Million
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $584,153 - $7.64 Million	-68,322 Reduced 39.67%	103,925 $8.45 Million
Q3 2021 Nov 12, 2021	SELL	$76.53 - $110.43 $397,802 - $574,015	-5,198 Reduced 2.93%	172,247 $18.2 Million
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $3.6 Million - $4.81 Million	42,141 Added 31.15%	177,445 $15.1 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $3.52 Million - $4.93 Million	32,110 Added 31.12%	135,304 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $432,994 - $829,480	5,441 Added 5.57%	103,194 $14.4 Million
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $143,023 - $195,901	-2,153 Reduced 2.16%	97,753 $7.96 Million
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $766,912 - $1.41 Million	17,414 Added 21.11%	99,906 $7.18 Million
Q1 2020 May 14, 2020	BUY	$44.49 - $93.39 $28,073 - $58,929	631 Added 0.77%	82,492 $3.67 Million
Q4 2019 Feb 14, 2020	BUY	$66.49 - $137.73 $342,157 - $708,758	5,146 Added 6.71%	81,861 $7.81 Million
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $152,644 - $441,830	4,924 Added 6.86%	76,715 $6.03 Million
Q2 2019 Aug 15, 2019	BUY	$36.0 - $44.73 $2.58 Million - $3.21 Million	71,791 New	71,791 $3.11 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$17.5 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$6.52 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$5.3 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.73 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.26 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account